21Shares, the Swiss issuer of exchange-traded products, has announced a new partnership with ARK Invest, the New York-based investment management firm, to launch a suite of digital asset exchange-traded funds (ETFs).
The first two ETFs in the suite, 21Shares ARK Autonomous Technology & Robotics ETF (ARKQ) and 21Shares ARK Genomic Revolution Multi-Sector ETF (ARKG), will invest in companies that are exposed to leading enabling technologies and those that are leading the way in utilizing innovative genomic technology.
Both ETFs will provide investors with comprehensive, low cost exposure to pages of publicly listed companies, allowing them to participate in the full spectrum of potential gains across the entire technology and life science revolution.
The ETFs will be the first in the U.S. to offer exposure to the booming field of robotics and autonomous technology, and the cutting edge gene editing and gene therapy field.
This partnership marks a big step forward for the digital asset space, as it brings a unique and diverse offering to the marketplace, allowing investors to capitalize on the growth of these two industries.
It also signals the growing legitimacy of the digital asset sector, as 21Shares and ARK Invest bring their respective strengths and expertise to the product suite and capitalize on the growth potential of the industries.